LGALS1, galectin 1, 3956

N. diseases: 362; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas
0.220 Biomarker group BEFREE Oral administration of SKLB-850 considerably suppressed the tumor growth in BCL xenograft models (Ramos and HBL-1) in a dose-dependent manner. 29340070 2017
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas
0.220 Biomarker group RGD Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma model. 16733672 2007
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas
0.220 Biomarker group BEFREE HBL-1 and HBL-2 appear useful for facilitating therapeutic investigations as well as immunologic and oncogenic studies in B-cell lymphomas. 3338018 1988